Cullinan Therapeutics, Inc. (CGEM) — DEF 14A Filings
All DEF 14A filings from Cullinan Therapeutics, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Cullinan Therapeutics Files DEF 14A on Executive Compensation
— Apr 25, 2025 Risk: low
Cullinan Therapeutics, Inc. filed a DEF 14A on April 25, 2025, detailing executive compensation and corporate governance matters for the fiscal year ending Dece -
Cullinan Therapeutics, Inc. Announces 2024 Annual Meeting of Stockholders
— May 16, 2024 Risk: low
Cullinan Therapeutics, Inc. (CGEM) filed a Proxy Statement (DEF 14A) with the SEC on May 16, 2024. The 2024 Annual Meeting of Stockholders for Cullinan Therapeu
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX